ReviewMedicine2025
Rapidly growing unilateral pseudoangiomatous stromal hyperplasia in a 10-year-old girl: A case report and review of management strategies.
Review in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationalePseudoangiomatous stromal hyperplasia (PASH) is a benign breast condition characterized by collagen fiber-segmented, blood vessel-like clefts lined by spindle cells, lacking red blood cells. First described by Vuitch et al in 1986, PASH typically presents with benign imaging features and is often identified incidentally during investigations for other breast conditions. PATIENT CONCERNS: This case study documents a rare instance of unilateral breast PASH in a 10-year-old girl, which demonstrated rapid growth over a short period, necessitating surgical excision. The patient presented with a rapidly enlarging, painless right breast mass over 2 months. Clinical examination revealed a soft, poorly defined mass measuring approximately 15 × 15 cm with overlying venous engorgement. Imaging studies, including ultrasound and magnetic resonance imaging, showed a low echogenicity mass with irregular borders and non-uniform enhancement. DIAGNOSES: Histological features consistent with PASH.
interventionsSurgical intervention confirmed a well-circumscribed mass with intact capsule. OUTCOMES: Postoperative follow-up over 1 year revealed no recurrence. LESSONS: PASH, typically diagnosed incidentally, can exhibit rapid growth and variable imaging characteristics, sometimes mimicking malignant conditions. Its occurrence in children and adolescents is uncommon, with most cases presenting as benign. The association with hormonal factors, observed in adults and those receiving hormonal treatments, suggests a potential link with endocrine changes. In conclusion, while PASH generally has a favorable prognosis, large or rapidly growing lesions in pediatric patients should be managed surgically to prevent potential functional and cosmetic issues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.